Dr. Khanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1580 Santa Barbara Blvd
Ste C
The Villages, FL 32159Phone+1 352-259-2159Fax+1 352-259-5731
Education & Training
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1985 - 1988
Maulana Azad Medical CollegeClass of 1983
Certifications & Licensure
FL State Medical License 1996 - 2027
MI State Medical License Active through 2015
NY State Medical License 1988 - 1999- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Solution Series EHR, e-MDs, 2011, 2013
Publications & Presentations
PubMed
- Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis.Elizabeth R Volkmann, Christopher P Denton, Martin Kolb, Marlies S Wijsenbeek-Lourens, Claire Emson
European Respiratory Review. 2024-04-01 - 8 citationsCentromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis.Souren Paul, Mark H Kaplan, Dinesh Khanna, Preston M McCourt, Anjan K Saha
Nature Communications. 2022-11-18 - 50 citationsLong-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open Label Extension of a Phase 3 Randomized Controlled Trial.Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Bridget Wagner, Mauro Zucchetto
American Journal of Respiratory and Critical Care Medicine. 2021-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
